Antidepressant effects of ketamine in depressed patients
Summary & key facts
In a small, carefully controlled study, researchers gave a single low dose of ketamine into a vein to people with major depression. Many people felt less depressed within hours, and the benefit lasted for several days after one treatment. The study was very small and short, so the results are promising but preliminary and need larger studies to know how well ketamine works long term and how safe it is over time.
- Researchers tested a single low, subanesthetic dose of ketamine given into a vein to people who were depressed.
- The study used a careful design where each person received ketamine at one time and a placebo at another, and neither the patients nor the raters knew which was given first.
- Many patients showed reduced depressive symptoms within hours after ketamine and had benefits that lasted for a few days after one dose.
- Some people had short-lived side effects such as feeling strange or disconnected while the drug was active, and these effects went away.
- The study included only a very small number of people, so its results are preliminary and cannot prove ketamine is a long-term antidepressant on its own.
Topics
Neurotransmitter Receptor Influence on Behavior Treatment of Major Depression Tryptophan and brain disordersCategories
Health Sciences Medicine PharmacologyTags
Alternative medicine Anesthesia Antagonist Antidepressant Behavioural despair test Depression (economics) Developmental psychology Economics Glutamate receptor Hippocampus Internal medicine Ketamine Ketamine hydrochloride Macroeconomics Medicine NMDA receptor Pathology Pathophysiology Placebo Psychology Randomized controlled trial Rating scale Receptor SalineSubstances
KetamineConditions & symptoms
Depression Sadness or low moodReferencing articles
Ketamine for Mental Health
Ketamine is reshaping mental health treatment for depression, PTSD, anxiety, chronic pain, and suicidal crisis.…
How Many Ketamine Treatments for Depression Are Needed?
The question on all the ketamine researchers’ lips right now is around the idea that…